W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.
Stryker (NYSE: SYK) officials say on social media that the company has made a couple of changes to its leadership team.
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Picard Medical, the company behind the SynCardia TAH, announced today that it plans to launch a new, FDA-cleared artificial ...
Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback